![](\"https:\/\/mms.businesswire.com\/media\/20260605285664\/en\/2824904\/5\/Glooko_Logotype_wTagline_Blue.jpg\")
<\/a><\/a>\nFor clinics caring for people with diabetes using insulin pump therapy, visibility of pump settings provides essential clinical context. Basal schedules, insulin-to-carbohydrate ratios, insulin sensitivity factors, blood glucose target ranges, closed-loop status and active insulin time all help care teams understand how insulin is being delivered and whether therapy adjustments may be needed. Historically, much of this information has lived outside the EHR isolated in external software, PDFs or screenshots, requiring clinicians and staff to toggle between systems, manually transcribe data or copy and paste pump settings into visit notes. Glooko\u2019s new Pump Settings EHR Integration is designed to replace that fragmented workflow with structured, discrete pump settings data visualized in EHR flowsheets that can be pulled automatically into clinical documentation using SmartText-style workflows, depending on EHR configuration.<\/p>
\n\u201cPump settings are the source of truth for how an insulin pump is delivering therapy; however, traditional documentation requires manual transcription of up to 24 different data points into the EHR,\u201d said Mark Clements, M.D., Ph.D., Chief Medical and Strategy Officer at Glooko. \u201cWhen clinicians can see settings such as basal rates, insulin-to-carbohydrate ratios, correction factors, active insulin time and closed-loop status in the same workflow as glucose data and the patient note, the visit becomes less about finding and transcribing information and more about acting on it. This integration, which is unique to Glooko, gives care teams a more complete view of insulin therapy today and creates the structured data foundation for more advanced clinical decision support in the future\u2014where discrete pump settings, glucose trends and other diabetes data can work together to surface more timely, actionable insights. By reducing reliance on incomplete, stale or manually transcribed information, Glooko is helping clinics make therapy adjustments with greater context, consistency and confidence.\u201d<\/p>
\nWhile EHRs remain the system of record, native EHR workflows often depend on the data already available inside the chart. Insulin pump settings, however, are generated and updated across a broad and evolving ecosystem of diabetes devices. Glooko adds a specialized, device-agnostic diabetes data layer that helps normalize pump data across manufacturers and deliver it back into the EHR as usable clinical context. The result is another intuitive management layer for clinics, specifically device data, EHR documentation, and diabetes care decisions working together in the workflow clinicians already use.<\/p>
\n\u201cFor diabetes clinics and health systems, integrating insulin pump settings directly into the EHR has been a long-desired functionality to eliminate a major source of administrative inefficiency,\u201d said Yaa Kumah-Crystal, M.D., M.P.H., M.S., Associate Professor of Biomedical Informatics and Pediatric Endocrinology at Vanderbilt University Medical Center (VUMC). \u201cBy removing the tedium of manual input from device readouts, the integrated process will improve data accuracy and lead to more consistent documentation, resulting in happier providers. This ultimately frees up the care team, including clinicians, nurses, and educators, to refocus their attention on the patient in front of them. For patients, this means smoother clinic visits with more directly accessible data to support the shared decision-making process. Holistically, access to this granular data now empowers health systems to track diabetes pump management parameters more precisely and advance targeted quality improvement and population health initiatives.\"<\/p>
\nThis latest Integration strengthens Glooko\u2019s overall EHR integration capabilities and builds on the company\u2019s commitment to connect device data, clinical workflows and patient engagement in a single, intuitive diabetes management platform. Glooko currently supports the centralization of diabetes data from more than 200 diabetes and health monitoring devices and integrates with leading EHR systems to help reduce platform switching and streamline care workflows.<\/p>
\n\u201cHealth systems are asking for diabetes data to be more connected, usable and embedded in the way care is actually delivered,\u201d said Rich Glenn, President of Connected Care at Glooko. \u201cBy bringing device-agnostic pump settings into EHR flowsheets, Glooko is helping clinics move beyond fragmented portals and manual documentation toward a more connected care experience for providers and people with diabetes.\u201d<\/p>
\nThis capability will be launched as part of the Glooko Web 26.2 and Mobile 16.16 product release the week of June 8, which also includes new features to enable population health, and efficient patient management experiences. Availability may vary by EHR configuration, device compatibility and market. All therapy decisions should be made by healthcare professionals using their clinical judgment and available patient information.<\/p>
\nAbout Glooko<\/b><\/p>
\nGlooko, Inc. is a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum. Glooko connects people with diabetes, healthcare providers and diabetes devices through solutions designed to simplify diabetes care, streamline clinical workflows and support more informed decisions. The company\u2019s connected care platform helps centralize diabetes data, integrate with EHR workflows and support care teams across outpatient and inpatient settings.<\/p>